What is the primary goal of using an inhaled corticosteroid in combination with a LABA?

The primary goal of using an inhaled corticosteroid in combination with a long-acting beta-agonist (LABA) is to manage long-term symptoms of respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD). Inhaled corticosteroids work by reducing inflammation in the airways, which helps to prevent symptoms such as wheezing, coughing, and shortness of breath. By maintaining lower levels of inflammation, they help to achieve better overall control of the disease.

The addition of a LABA enhances this treatment by providing bronchodilation, which opens the airways and improves airflow over an extended period. This combination therapy addresses both the underlying inflammatory process and the immediate airway constriction, leading to a more comprehensive approach in managing chronic respiratory conditions effectively.